Stocklytics Platform
Asset logo for symbol IGMS
IGM Biosciences
IGMS58
$1.38arrow_drop_up0.71%$0.01
Penny Stock
Asset logo for symbol IGMS
IGMS58

$1.38

arrow_drop_up0.71%

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•
•

IGM Biosciences (IGMS) Stocklytics Forecast

The stock price of IGM Biosciences Inc (IGMS) has been the subject of much speculation and analysis among investors and analysts. Many are eager to predict the future price of IGMS and make investment decisions based on these forecasts. While it is difficult to accurately predict the stock price of any company, there are some factors that can give us an idea of what to expect for IGM Biosciences Inc. One factor to consider is the company's financial performance and industry trends.
IGM Biosciences Inc is a biotechnology company that focuses on the development of novel immunoglobulin M (IgM) antibodies for the treatment of cancer. The company has a strong pipeline of product candidates, including several in early-stage clinical trials. As the demand for innovative cancer treatments continues to grow, IGM Biosciences Inc is well-positioned to benefit from this trend. Additionally, the company has a robust research and development team that is dedicated to advancing the science behind their product candidates.
add IGM Biosciences to watchlist

Keep an eye on IGM Biosciences

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for IGM Biosciences (IGMS) stock?

Analysts have set a target price of $23.33 for IGM Biosciences (IGMS), based on forecasts from 24 analysts. The predicted price range extends from a high of $55 to a low of $7. This represents a potential increase of up to 3.87K% and a decrease of 405.42% from the current price of $1.39. These forecasts are as of 2022 Jun 01.
help

What are the analyst ratings for IGM Biosciences (IGMS) stock?

The analyst ratings for IGM Biosciences (IGMS) are distributed as follows: 0 analysts recommend buying, 6 have a neutral stance, and 1 suggest selling. The prevailing sentiment among the total of 7 analysts leans towards a neutral rating. These ratings indicate the general sentiment among the analysts covering IGM Biosciences .
help

What is the AI price prediction for IGM Biosciences (IGMS) stock?

At present, there is no AI or machine-learning-based price prediction available for IGM Biosciences (IGMS) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Take Your Investments to a Whole New Level